Cadoret-Manier Onaiza — SEC Form 4 filings
SEC reporting owner CIK 1799355. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-01-17 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 9,851 shares, $493,164 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 5,564 shares @ $50.42 ($280,520) in IONIS PHARMACEUTICALS INC, filed 2024-01-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| IONIS PHARMACEUTICALS INC (IONS) | EVP,Chf GL Pdt Str & Oper Ofc | 4 | — | 3 legs · 9,851 sh · $493,164 | 5 |
| Ventyx Biosciences, Inc. (VTYX) | Director | 4 | — | — | 8 |
| ARDELYX, INC. (ARDX) | Director | 3 | — | — | 5 |
Form 4 filings — Cadoret-Manier Onaiza
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-18 | 4 | ARDELYX, INC. (ARDX) | Grant/award (A): 26,455 @ $0 · Grant/award (A): 39,715 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Ventyx Biosciences, Inc. (VTYX) | Disposition to issuer (D): 33,000 (derivative) · Disposition to issuer (D): 40,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 15,937 (derivative) · Disposition to issuer (D): 20,427 (derivative) | EDGAR |
| 2025-06-23 | 4 | ARDELYX, INC. (ARDX) | Grant/award (A): 41,551 @ $0 · Grant/award (A): 54,059 (derivative) @ $0 | EDGAR |
| 2025-06-06 | 4 | Ventyx Biosciences, Inc. (VTYX) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-09-04 | 4/A | IONIS PHARMACEUTICALS INC (IONS) | Sale (S): 2,162 @ $49.60 | EDGAR |
| 2024-06-17 | 4 | ARDELYX, INC. (ARDX) | Grant/award (A): 40,243 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Ventyx Biosciences, Inc. (VTYX) | Grant/award (A): 33,000 (derivative) @ $0 | EDGAR |
| 2024-02-02 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 4,140 @ $0 · Sale (S): 2,125 @ $49.60 | EDGAR |
| 2024-01-23 | 4 | Ventyx Biosciences, Inc. (VTYX) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-01-18 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Option exercise (M): 15,062 @ $0 · Sale (S): 5,564 @ $50.42 · Option exercise (M): 15,062 (derivative) @ $0 | EDGAR |
| 2024-01-17 | 4 | IONIS PHARMACEUTICALS INC (IONS) | Grant/award (A): 27,000 (derivative) @ $0 · Grant/award (A): 32,400 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1799355 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →